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Abstract 
Background: Exercise, when performed on a regular basis, is a well-accepted strategy to improve vascular function 
in patients with type 2 diabetes. However, the exercise intensity that yields maximal adaptations on structural and 
functional indices in patients with type 2 diabetes remains uncertain. Our objective was to analyze the impact of a 
1-year randomized controlled trial of combined high-intensity interval training (HIIT) with resistance training (RT) vs. 
a combined moderate continuous training (MCT) with RT on structural and functional arterial indices in patients with 
type 2 diabetes.
Methods: Patients with type 2 diabetes (n = 80) were randomized into an exercise intervention with three groups: 
control, combined HIIT with RT and combined MCT with RT. The 1-year intervention had 3 weekly exercise sessions. 
High-resolution ultrasonography of the common carotid artery and central and peripheral applanation tonometry 
were used to assess the changes in structural and functional arterial indices. Generalized estimating equations were 
used to model the corresponding outcomes.
Results: After adjusting the models for sex, baseline moderate-to-vigorous physical activity, and mean arterial pres-
sure changes, while using the intention-to-treat analysis, a significant interaction was observed on the carotid intima-
media thickness (cIMT) for both the MCT (β = − 4.25, p < 0.01) and HIIT group (β = − 3.61, p < 0.01). However, only 
the HIIT observed favorable changes from baseline to 1-year on peripheral arterial stiffness indices such as carotid 
radial arterial pulse wave velocity (β = − 0.10, p = 0.044), carotid to distal posterior tibial artery pulse wave velocity 
(β = − 0.14, p < 0.01), and on the distensibility coefficient (β = − 0.00, p < 0.01). No effect was found for hemodynamic 
variables after the intervention.
Conclusions: Following a 1-year intervention in patients with type 2 diabetes, both the MCT and HIIT group reduced 
their cIMT, whereas only the HIIT group improved their peripheral arterial stiffness indices and distensibility coefficient. 
Taken together, HIIT may be a meaningful tool to improve long-term vascular complications in type 2 diabetes.
Trial registration clinicaltrials.gov ID: NCT03144505
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Introduction
For most patients with diabetes mellitus, micro- and 
macro-vascular complications are the major culprit for 
increased mortality and morbidity [1]. With the onset 
of diabetes, subclinical manifestations of cardiovascu-
lar pathology occur, which in turn may lead to ischemic 
heart disease and carotid stenosis [2, 3]. Among the sub-
clinical markers, carotid intima-media thickness (cIMT) 
and pulse wave velocity (PWV) are well established 
structural [4] and arterial stiffness measurements [5], 
associated with cardiovascular disease (CVD) risk [6, 7]. 
Patients with type 2 diabetes have increased cIMT and 
PWV when compared with non-diabetic patients [5, 8]. 
Prevention and treatment of these markers would likely 
reverse or delay the vascular changes that occur in type 2 
diabetes, improving endpoint outcomes [9, 10].
Current guidelines for patients with type 2 diabetes 
largely advocate the importance of physical activity as 
a therapeutic tool to improve and control several CVD 
risk factors including glycemic control, blood pressure, 
and endothelium function. In line with these findings, 
the American Diabetes Association (ADA) states that 
patients with type 2 diabetes should accumulate at least 
150 min of moderate-intensity physical activity [40–60% 
peak oxygen uptake or 75 min of vigorous-intensity phys-
ical activity (60–85% peak oxygen uptake)] per week to 
maintain or improve health [11, 12]. More recently, stud-
ies have reported that performing high intensity interval 
training (HIIT) can elicit the same or even additional 
cardiovascular and glycemic adaptations when compared 
with moderate continuous training (MCT) [13, 14].
While our recent trial [15] suggested that a combina-
tion of HIIT with RT had no impact on body composi-
tion and glycemic control variables following a 1-year 
intervention, the effect of HIIT on arterial stiffness 
and structural indices in patients with type 2 diabetes 
remains to be determined. In fact, when considering the 
interventions that included patients with type 2 diabetes 
and analyzed the impact of HIIT on structural and arte-
rial stiffness measurements, we only found a single case 
addressing these variables with a time span of 12-weeks 
[16]. Moreover, to the best of our knowledge, there are no 
investigations comparing the effects of different types of 
aerobic exercise (HIIT vs. MCT) alone or in combination 
with resistance training (combined exercise) on arterial 
stiffness and structural indexes, which are considered the 
most effective strategies for achieving glycemic control 
[17].
Therefore, the purpose of the present 1-year rand-
omized controlled trial was to investigate the effects 
of a combined HIIT and RT vs. a combined MCT and 
RT on central and peripheral arterial stiffness indices 
in patients with type 2 diabetes. We hypothesized that 
1-year of a combined HIIT and RT protocol will induce 
more improvements in cIMT, and on central and periph-
eral PWV, as well as other stiffness measurements, when 
compared to a combined MCT with RT protocol.
Materials and methods
Recruitment process
A randomized controlled trial conducted in the region 
of greater Lisbon, between February 2014 to July 2016, 
included patients with type 2 diabetes and an exer-
cise intervention with a 1-year duration (D2FIT pro-
ject) (Fig. 1). The number and the characteristics of this 
sample are the same as the one used in our previous 
published study [15], hence a total of 80 patients were 
randomized to three distinct groups. In order to be eli-
gible, participants had to be adults diagnosed with type 
2 diabetes [18], have no major macro or micro vascular 
complications, have a body mass index (BMI) < 48  kg/
m2, and have no physical limitations that would pre-
vent them from participating in an exercise program. 
Power and sample size calculations (G-Power, Version 
3.1.3) were based on a predicted glycated hemoglobin 
(HbA1c) difference of 0.66 HbA1c units with a SD of 
effect of 1.2 HbA1c units, α = 0.05, 1 − β = 0.80 and an 
expected dropout rate of 10% [19]. However, for this sec-
ondary analysis the power and sample size calculations 
were based on changes in aortic PWV. Given a predicted 
PWV difference of 1.21  m  s−1 with a SD of 1.4  m  s−1, 
α = 0.05, 1 − β = 0.80, the sample used in this study was 
powered for this secondary analysis [20]. This investiga-
tion was carried out in accordance with the recommen-
dations of the Declaration of Helsinki for Human Studies. 
The protocol was approved by the Ethics Committee of 
the Portuguese Diabetes Association (approval number: 
07/17/2013). Written informed consents were obtained 
from all participants before and prior to any protocol-
specific procedures.
Research design
The current investigation is a secondary analysis of a 
1-year randomized control trial (D2FIT) developed to 
analyze the impact of exercises with different inten-
sities on glycated hemoglobin (clinicaltrials.gov ID: 
NCT03144505) [15]. The D2FIT had two intervention 
groups (MCT with RT, and HIIT with RT) and a control 
group. An external researcher used a computer-gener-
ated list of random numbers, to allocate the patients 
to the groups in a 1:1:1 ratio. The observers from each 
assessment were blinded to group randomization.
The changes of arterial stiffness, structural indexes, 
and hemodynamic variables were assessed as second-
ary outcomes at baseline and at 1-year follow-up. All 
evaluations were performed during a single visit, except 
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Fig. 1 Study flow chart
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cardiorespiratory fitness (CRF) assessment, which was 
evaluated on a separate day. Participants were required to 
fast for at least 8 h prior to the visit, avoid alcohol con-
sumption for 24 h, and consume a normal evening meal 
the night before the visit. Participants that were eligi-
ble were randomized after completing all the intended 
assessments.
Exercise training
The non-exercise group (control) had an initial orienta-
tion session, with standard counseling and information 
regarding general physical activity guidelines. Addition-
ally, once in every 4 weeks, the control group, alongside 
with the MCT and HIIT group, met for thematic sessions 
with broad topics such as nutrition, physical activity, and 
clinical complications from diabetes. All participants 
from the intervention groups (MCT and HIIT) per-
formed 1-year of supervised exercise sessions three times 
per week while monitored by certified exercise physiolo-
gist and the use of a heart rate polar band (Polar T-31, 
USA). Both MCT and HIIT were designed to have the 
same energy expenditure. The duration of the exercise 
sessions was calculated using a weekly target of 10 kcal/
kg and considering individual peak oxygen uptake. For 
example, considering a patient with a measured  VO2 peak 
of 24.2 ml/kg/min, a body weight of 81.2 kg, a standard 
3.5  ml/kg/min of resting  VO2, while exercise at 60% of 
 VO2reserve (15.9 ml/kg/min) during that month, one could 
expect an energy expenditure of 6.5  kcal/min. When 
multiplying the body weight for 10 kcal/week we would 
have 812.5 kcal/week, meaning that at a rate of 6.5 kcal/
min, this patient would need to spend 125.5 min/week or 
41.8 min of cycling per session. For the HIIT, the inten-
sity calculations were performed with a similar approach 
as described above, considering that 50% of the exercise 
sessions were performed at 70–90% of the  VO2reserve, and 
the remaining exercise performed at an intensity equiva-
lent to 40–60% of the  VO2reserve. Considering the example 
above, this is equivalent to approximately 34 min/session, 
including 17 HIIT 1-min bouts at 90% of the  VO2reserve. 
Throughout the whole year of intervention both groups 
went through a planned periodization exercise prescrip-
tion with individualized intensity based upon heart rate 
reserve (HRR) to gradually introduce the exercise pre-
scriptions. In phase 1 (preparation phase, weeks 1–4), 
which was similar for both groups, participants per-
formed continuous exercise of moderate intensity (40–
60% of the HRR). For the MCT group, which only had an 
additional phase (training phase, weeks 5–52), partici-
pants performed continuous cycling at 40 to 60% of the 
HRR.
In the HIIT group, the objective of phase 2 (train-
ing phase with lower intensity phase, weeks 5–8) was to 
progressively introduce the HIIT program. During weeks 
5–6, participants performed bouts of 2  min at 70% of 
the HRR followed by 1  min at 40–60% of the HRR and 
increased to bouts of 80% of the HRR followed by 1 min 
at 40–60% of the HRR during weeks 7–8. In phase 3 
(training phase with higher intensity, weeks 9–52), par-
ticipants performed 1  min of exercise at 90% of their 
HRR followed by 1  min resting at 40–60% of the HRR. 
Throughout the intervention, participants in both groups 
were instructed to exercise in the upper limit of the pre-
scribed exercise intensity. In both groups, after the aero-
bic component, participants performed a whole-body RT, 
which included 1 set of 10–12 repetitions of upper and 
lower limbs exercises. A full description of the exercise 
prescription for both MCT and HIIT can be found else-
where [15].
Anthropometry
Participants were weighed to the nearest 0.01  kg while 
wearing minimal clothes and without shoes on an elec-
tronic scale (Seca, Hamburg, Germany). Height was 
measured to the nearest 0.1 cm with a stadiometer (Seca, 
Hamburg, Germany) according to the standardized pro-
cedures described elsewhere [21]. BMI was calculated as 
body mass (kg)/height2 (m). BMI was further categorized 
into normal (< 25  kg/m2), overweight (25–29.9  kg/m2), 
and obese (≥ 30  kg/m2). Waist circumference measure-
ment was taken with the participant in a standing posi-
tion over the naked skin to the nearest 0.1 cm. The tape 
was applied horizontally just above the uppermost lateral 
border of the right ilium at the end of normal expiration 
[22]. The mean of two measurements was considered. 
If the two measurements differed by more than 1 cm, a 
third measurement was taken, and the two closest meas-
urements were averaged.
Brachial blood pressure
The right and left brachial SBP and DBP were measured 
following at least 15  min with the participants in the 
supine position using an automated oscillometric cuff 
(HEM-907-E, Omron, Tokyo, Japan). Two measurements 
were taken and if these values deviated by > 5 mmHg, a 
third measurement was performed [23].
Conduit artery intima‑media thickness
The distance between the leading edge of the lumen–
intima interface and the leading edge of the media–
adventitia interface of the far wall of the right carotid 
artery was used to define cIMT. This measurement was 
performed using an ultrasound scanner equipped with 
a linear 13 MHz probe (MyLab One, Esaote, Italy) [24], 
and distension curves were acquired within a segment of 
the carotid artery about one cm before the flow divider. 
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The CV for repeated measurements in our laboratory 
for cIMT and carotid diameter are 3.02% and 1.49%, 
respectively.
Carotid blood pressure
The carotid blood pressure was estimated by assuming 
a linear relationship with the distension waveform [25], 
in which the mean arterial pressure (MAP) and brachial 
DBP are constant over the arterial tree. This enables the 
calculation of a scaling factor (δ), considering that the 
integral over time of the distension curve is automatically 
calculated by the quality arterial stiffness software. The 
local pressure was assessed using the following formula:
where ΔD(t) is the distension waveform.
Carotid arterial stiffness indices
The carotid arterial stiffness measurement was conducted 
on the right side, with the patient in the supine position 
after at least a 15 min resting period. An ultrasound scan-
ner equipped with a linear 13 MHz probe (MyLab One, 
Esaote, Italy) with Quality Arterial Stiffness technology, 
was used approximately one cm before the bifurcation. 
This allows the calculation of carotid stiffness indices: 
PWV (m/s), distensibility coefficient (1/KPa), compli-
ance coefficient  (mm2/kPa), stiffness index α and β. The 
coefficients of variation for repeated measurements in 
our laboratory for carotid distensibility, compliance, stiff-
ness index α and β, and carotid SBP are 0%, 2.87%, 3.70%, 
3.18% and 2.15%, respectively.
Contralateral pulse wave velocity
Pulse wave velocity was measured by applanation tonom-
etry immediately after ultrasound imaging. A single 
operator located the carotid, femoral, radial, and distal 
posterior tibial arteries on the left side of the body and 
marked the point for capturing the corresponding pres-
sure curves with two specific pressure sensitive transduc-
ers. The distance between the carotid and femoral and 
radial and distal posterior tibial arteries were measured 
directly into the Complior Analyse software (ALAM 
Medical, Paris, France). PWV values obtained from the 
carotid to femoral artery (CF PWV), carotid to radial 
artery (CR PWV), and carotid to distal posterior tibial 
artery (CD PWV) were taken as indices of central/aor-
tic and peripheral arterial stiffness for upper and lower 
limb, respectively. A second observer immediately evalu-
ated the quality of the PWV records. Whenever a con-
tinuous decrease before the sharp systolic upstroke 
was not clearly seen, or the tolerance was above 5  ms, 
a second measure was taken. The coefficients of varia-
tion for repeated measurements in our laboratory for 
cSBP(t) = δ ·�D(t)+ bDBP,
aortic, upper limb and lower limb PWV are 2.95%, 9.10%, 
respectively.
Physical activity
Participants were asked to wear an accelerometer (Acti-
graph, model GT1  M model, Pensacola, Florida) on the 
right hip, near the iliac crest during 4 consecutive days, 
including 2  weekdays and 2  weekend days. The devices 
were activated on raw mode with a 100  Hz frequency, 
and posteriorly downloaded into 15-s epochs (Actilife 
v.6.9.1). The Troiano et al. cut points and wear time vali-
dation criteria were used to define the time spent in each 
intensity and to define valid measurements [26].
Cardiorespiratory fitness
Cardiorespiratory fitness was determined using a Bruce 
standard protocol on a motorized treadmill to exhaus-
tion (model Q-65, Quinton, Cardiac Science Corp; Both-
ell, WA, USA). All graded exercise tests were monitored 
using a 12-lead electrocardiogram PC-based acquisition 
module (model Quark C12, Cosmed, Rome, Italy) with 
Cosmed software (Cosmed, Rome, Italy). Inspired and 
expired gases were continuously analyzed, breath-by-
breath, through a portable gas analyzer (K4b2, Cosmed, 
Rome, Italy). Participants exercised until at least two of 
the following test termination criteria were reached: (1) 
participants volitional fatigue; (2) respiratory exchange 
ratio reached 1.1 or higher; (3) participants reached pre-
dicted maximal heart rate; (4) oxygen uptake did not 
increase in spite of increasing workload. The highest 20 s 
value for peak oxygen consumption (ml/kg/min) attained 
in the last minute was used in the analysis, and termed 
CRF from here on.
Laboratory measurements
Participants underwent biochemical assessments, includ-
ing the analysis of glycated hemoglobin (HbA1c). Blood 
samples were collected from an indwelling catheter and 
drawn into chilled, heparinized tubes and centrifuged 
rapidly to avoid glycolysis. HbA1c was analyzed by 
immunoassay (auto analyzer Hb9210 Premier).
Statistical analysis
The data that support the findings of this study are avail-
able from the corresponding author upon reasonable 
request. Data analyses were performed using IBM SPSS 
Statistics version 22.0 (SPSS Inc., an IBM Company, 
Chicago, Illinois, USA). Descriptive statistics including 
mean ± SD were calculated for all the main and second-
ary outcome variables. Normality was tested using Q–Q 
plots. Comparisons between groups were performed 
using independent sample ANOVA tests or the non-
parametric Mann–Whitney–Wilcoxon approach. Due to 
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the correlated nature of the data and repeated measure-
ments taken on each assessment, generalized estimating 
equations were used to model outcomes while allowing 
us to control for potential confounders (i.e. sex, baseline 
moderate-to-vigorous physical activity (MVPA), MAP 
changes). A least significant difference post hoc test was 
used to estimate the between-group and within-group 
effects on several cardiometabolic outcomes. A linear 
distribution for the response was assumed and an autore-
gressive correlation matrix was set to the data. For all 
the outcomes an intention-to-treat analysis (ITTA) was 
performed using all participants that were initially ran-
domized. Since the D2FIT was designed as an effective-
ness investigation, an additional per-protocol analyses 
(PPA) was performed, which included only a subgroup of 
participants that completed the investigation and those 
in the intervention groups that had at least 70% of adher-
ence to the total number of trainings [27].
Results
Baseline descriptive characteristics of the participants 
are reported in Table 1 by intervention group and for the 
ITTA and PPA. The prevalence of overweight and obesity 
was 83.8%, with 46.3% of the total sample having uncon-
trolled HbA1c, as defined by ADA criteria (> 7%).
At baseline there were no differences between the 
intervention groups, in both the ITTA and PPA, except 
for baseline MVPA, which was higher in the HIIT group. 
A total of 55 participants completed the intervention, 
with mean adherence percentage values of 86% and 87% 
for the MCT and HIIT group, respectively. The dropout 
rates were 11%, 18%, and 24% for the control, MCT and 
HIIT, respectively (Fig. 1).
Table  2 presents the PPA results for hemodynamic 
variables and structural and arterial stiffness indices at 
baseline and following 12  months, as well as the inter-
action effect of time with each group (MCT vs. HIIT vs. 
control). Following adjustments for baseline MVPA, sex 
and MAP, we found an interaction effect for the cIMT 
in both the MCT (β = − 5.02, p = 0.032) and the HIIT 
(β = − 3.68, p = 0.045) intervention groups vs. the con-
trol group. However, for the distensibility coefficient 
(β = 0.00, p = 0.0.46) and CD PWV (β = − 0.20, p > 0.01), 
only the HIIT group had a significant interaction effect 
following a 1-year of intervention. Hemodynamic vari-
ables, as assessed by brachial blood pressure and carotid 
blood pressure, did not change throughout the interven-
tion in both exercise groups. Following the same trend, 
we observed no interaction effect for the CF PWV for all 
intervention groups (p > 0.05).
Figure  2 depicts data from the changes that occurred 
between baseline and 1-year follow-up for the structural 
and arterial stiffness indices using the PPA. Participants 
from the HIIT intervention group decreased their cIMT, 
CR PWV, and CD PWV values by, 1.1%, 10.0% and 11.2%, 
respectively. With similar favorable changes, the HIIT 
group also increased the distensibility coefficient by 8.9%. 
When considering the MCT group, we observed changes 
only for the cIMT variable, with a decrease of 1.4% from 
pre- to post-intervention.
Table 1 Baseline characteristics of the participants by group in the ITTA and in the PPA
MCT moderate continuous training, HIIT high intensity interval training, BMI body mass index, MVPA moderate-to-vigorous physical activity, HbA1c glycated 
hemoglobin, WC waist circumference, VO2peak peak oxygen uptake
* Differences between group at baseline values (p < 0.05)
a Skewed values are presented as median ± inter quartile range
Intention to treat baseline values (values are 
presented mean ± SD)
Per‑protocol baseline values (values are presented 
mean ± SD)
Control (n = 27) MCT (n = 28) HIIT (n = 25) p‑value Control (n = 22) MCT (n = 16) HIIT (n = 13) p‑value
Age (yrs) 59.0 ± 8.1 59.7 ± 6.5 56.7 ± 8.3 0.575 60.8 ± 7.5 60.4 ± 6.8 58.9 ± 7.5 0.814
Woman (%) 48.1 53.6 40.0 0.612 50.0 56.3 30.8 0.367
Hypertension medication (%) 48.1 50.0 52.0 0.579 54.5 37.5 53.8 0.538
Oral antidiabetic medication 
(%)
96.3 92.9 84.0 0.388 95.5 93.8 92.3 0.512
Diabetes Diagnosis (yrs)a 5.0 ± 3.0 8.0 ± 9.0 5.0 ± 6.0 0.086 4.5 ± 3.25 8.0 ± 9.0 6.0 ± 6.0 0.091
Weight (kg) 84.1 ± 15.8 82.7 ± 13.3 81.6 ± 16.8 0.906 85.9 ± 15.7 82.0 ± 13.8 84.2 ± 19.2 0.799
Height (cm) 165.5 ± 9.4 163.2 ± 8.4 164.8 ± 8.1 0.545 164.5 ± 9.5 162.9 ± 9.2 166.6 ± 8.1 0.615
BMI (kg/m2) 30.7 ± 5.0 31.1 ± 5.0 30.1 ± 5.7 0.722 31.7 ± 4.7 31.0 ± 5.5 30.2 ± 5.9 0.506
WC (cm) 103.0 ± 12.4 103.8 ± 11.3 102.7 ± 14.3 0.914 103.3 ± 15.8 103.5 ± 12.2 103.3 ± 15.8 0.946
MVPA (min/day)a 18.4 ± 26.4 30.5 ± 4.8 38.9 ± 29.4 0.008* 15.9 ± 23.1 38.1 ± 41.6 38.9 ± 30.1 0.012*
VO2peak (ml/kg/min) 25.9 ± 5.5 24.1 ± 3.2 27.1 ± 6.3 0.143 25.1 ± 5.6 23.9 ± 3.7 26.6 ± 5.3 0.345
HbA1c (mmol/mol)a 49.7 ± 20.7 53.2 ± 22.7 49.0 ± 12.3 0.545 48.1 ± 16.7 47.2 ± 22.1 50.8 ± 12.6 0.828
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Table 3 summarizes the results of the ITTA for hemo-
dynamic variables and structural and arterial stiff-
ness indices. When considering the ITTA, and after 
adjusting for sex, MAP and baseline MVPA, the results 
remained similar as the PPA for all the outcomes, with 
MCT (β = − 4.25, p < 0.01) and HIIT (β = − 3.61, p < 0.01) 
intervention groups decreasing their cIMT values from 
baseline to post-intervention. The HIIT group also had a 
favorable effect on the CD PWV (β = − 0.14, p < 0.01) and 
on the distensibility coefficient (β = 0.00, p < 0.01), similar 
to those observed in the PPA, while having an additional 
effect on CR PWV (β = − 0.10, p = 0.044). As far as all 
other variables are concerned, no interaction effects were 
observed for both intervention groups.
Discussion
To our knowledge, this is the first randomized controlled 
trial spanning a 1-year intervention with supervised exer-
cise sessions analyzing the effectiveness of a MCT com-
bined with RT vs. HIIT combined with RT on structural 
and functional arterial indices in patients with type 2 dia-
betes. This investigation affords experimental evidence 
that a long-term MCT combined with RT and HIIT com-
bined RT improves cIMT. Moreover, the results of the 
study highlights HIIT as a promising long-term exercise 
strategy to delay and counter the changes in arterial stiff-
ness indices, more specifically on CD PWV, CR PWV, 
and on the distensibility coefficient, which are typically 
compromised in ageing and in type 2 diabetes, with likely 
implications on the progression of CVD.
Type 2 diabetes is strongly linked to central obesity, 
which in turn is associated with increased arterial stiff-
ness [28]. Indeed, patients with type 2 diabetes have 
higher values of arterial stiffness when compared to 
matched controls [29–31]. Regarding the benefits of 
HIIT on vascular health in patients with type 2 diabetes, 
most of the literature available derives from flow medi-
ated dilation (FMD) studies. Recent reviews and meta-
analysis have found different results on the benefits 
of HIIT on FMD in patients with type 2 diabetes when 
compared to MCT [32–34]. Unlike FMD, PWV provides 
structural alongside with functional health information 
of the arterial wall and can be used as a complementary 
measurement to that of FMD. In our investigation, base-
line values for CF PWV and CD PWV were 13.0 ± 4.0 
and 9.6 ± 1.9, respectively, which are slightly higher than 
the ones observed in other studies, especially for the CF 
PWV [5, 16]. Exercise seems to attenuate arterial stiffness 
in healthy subjects and in patients with type 2 diabetes, 
but the effect of different exercise intensities still remain 
controversial. Epidemiological evidence suggests that the 
largest impact on vascular risk occurs when practicing 
exercise at lower volumes and intensities [35, 36]. How-
ever, most of the studies included in these meta-analyses 
and reviews used high-intensity continuous training to 
analyze the impact of exercise intensity on vascular risk 
[37]. Engaging in vigorous PA for prolonged periods of 
Fig. 2 Changes in structural and hemodynamic variables using the per-protocol analysis. Dashed lines represent mean values for each intervention 
group
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time in a continuous fashion results in increased oxida-
tive stress due to the elevated ROS production, which 
could jeopardize nitric oxide bioavailability and mitigate 
the positive effects of exercise on the endothelium [36, 
38]. By limiting exercise at higher intensities to periods of 
shorter bouts, HIIT could potentially limit these effects 
on nitric oxide bioavailability, since the exercise bout is 
always followed by a recovery period [34]. Nevertheless, 
notwithstanding the potential role that intensity plays on 
improving vascular health, the increased energy expendi-
ture derived from physical activity has been associated 
with a reduced risk of CVD [39].
The D2FIT investigation hopes to shed light into this 
intensity subject by adding valuable long-term experi-
mental evidence of the effects of different exercise inten-
sities on vascular health in people with type 2 diabetes. 
Our findings suggest that after a 1-year intervention a 
reduction in the peripheral arterial stiffness, particularly 
in the CD PWV (1.1  m/s) and CR PWV (1.2  m/s), was 
only observed in the HIIT group, but no changes were 
observed for CF PWV. Central stiffness worsens within 
groups, but CD PWV tends to improve. Since CF PWV 
is a component of CD PWV, one can hypothesize that 
peripheral stiffness improves, perhaps to an even greater 
extent than is suggested by the CD PWV data alone. 
Nonetheless, only a reduction in CF PWV is associated 
with reduced risk of cardiovascular and all-cause mortal-
ity [40]. While using a similar HIIT protocol to the one of 
this investigation, Francois et al. [16], analyzed the effects 
of HIIT on arterial stiffness in patients with type 2 dia-
betes. Following a 12-week intervention, the HIIT group 
observed a reduction of 1.6 m/s in the CF PWV, whereas 
no changes were observed for CR PWV. The differences 
between these results and the ones from our investigation 
might be related with the duration of the intervention as 
well as the period in which these variables were assessed. 
The D2FIT investigation was designed as a 1-year inter-
vention that had two time point assessments for the vas-
cular health variables (baseline and 1-year follow-up). 
Therefore, the results observed after 1-year intervention 
might not reflect the short (2–4  weeks) and medium-
term changes that occur with the exercise training on 
vascular health, which were not assessed in our investiga-
tion due to the lack of mid-point assessments. Neverthe-
less, a recent meta-analyses that investigated the impact 
of different exercise modalities on both central and 
peripheral arterial stiffness in adults, observed that only 
aerobic exercise had an effect on arterial stiffness, specifi-
cally on peripheral (CR PWV and CD PWV) rather than 
on central indices (CF PWV) [41]. This effect was not sig-
nificant in patients who used combined MCT with RT, 
which follows the same results of our intervention.
These results for the aerobic exercise alone might 
be explained by the properties of peripheral arteries, 
which are more muscular and stiffer than central, more 
elastic arteries [36], allowing for their larger adapta-
tions in response to exercise training. Additionally, the 
HIIT cycling exercise program maximized muscle fiber 
recruitment through engagement og a larger amount of 
skeletal muscle mass, which may have promoted adapta-
tions on local muscle fibers and the on blood vessels that 
supply them [42]. We can speculate that the superior 
adaptations observed on peripheral stiffness (CD PWV) 
might be due to the characteristics of the HIIT program, 
which generated more local adaptations when compared 
to MCT. As far as the impact of HIIT combined with RT 
is concerned, there may be an interference effect on arte-
rial stiffness remodeling, favoring exercises performed at 
higher intensities. Another possible explanation for the 
superior benefits of HIIT on arterial stiffness, lies on the 
ability of HIIT to promote an up-regulation of PGC-1α in 
the local muscle, which is superior to that observed fol-
lowing MCT [43, 44]. Overexpression of PGC-1α in the 
endothelial cells that have the potential to improve anti-
oxidant defenses of the mitochondria [45]. Therefore, 
the superior results on the vascular function observed in 
HIIT, could partly be due to a decrease in ROS, without 
affecting NO availability [34]. Alongside with the struc-
tural changes, the HIIT group also observed an increase 
in the distensibility coefficient of the carotid artery, 
whereas no changes were observed for the MCT group. 
Such results are important for vascular health, since arte-
rial stiffness and arterial dispensability deteriorate with 
ageing and type 2 diabetes [46, 47].
Beyond the arterial stiffness adaptations, we observed 
structural changes in the cIMT favoring both the MCT 
and HIIT groups. cIMT is a well-established marker for 
predicting future cardiovascular events in patients with 
type 2 diabetes [48]. The fact that a 1-year intervention 
promoted a significant reduction in cIMT is impor-
tant because the carotid artery is highly susceptible to 
the development of atherosclerosis and is an important 
marker for identifying patients who are at higher risk of 
developing micro- and macrovascular complications [49]. 
To our knowledge, this is the first investigation to analyze 
which type of exercise induces greater improvements on 
the cIMT (HIIT vs. MCT). So far, the experimental evi-
dence addressing this topic has focused on randomized 
control trials with only one type of exercise. Francois 
et al., with a 12-week intervention using HIIT, found no 
effect of the exercise intervention on cIMT. The lack of 
results might be explained by the short duration of the 
investigation, which may not be enough time to observe 
structural changes in the intima-media layer. With simi-
lar results, a 1-year intervention using a combined MCT 
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with RT protocol also observed no changes in cIMT in 
patients with type 2 diabetes. However, there was an 
interaction effect between the exercise group and the 
patients without atherosclerotic plaques, where patients 
without early stages of atherosclerotic disease improved 
their cIMT [50]. The proposed mechanisms mediat-
ing the improvements in cIMT suggest that repeated 
exposure to shear stress, associated with exercise train-
ing, represents a key stimulus for arterial remodeling 
[51]. The importance of the nitric oxide pathway and the 
lower production of vascular adhesion molecules are also 
mechanisms through which exercise induced shear stress 
can improve structural remodeling [51, 52]. Exercise is 
known to improve hyperglycemia and elevated levels of 
insulin, which are characteristic of patients with type 2 
diabetes and have been shown to impair the production 
and availability of nitric oxide [42]. A recent review [53], 
has highlighted the potential of HIIT to improve gly-
cemic control to a greater extent, when compared with 
MCT, hence providing a potential link between insulin 
resistance and improved vascular health.
As far as CRF is concerned, and as previously reported 
[15], we observed favorable changes in CRF, but only 
in the MCT with RT group. Increased CRF values are 
strongly associated with improvements in vascular health 
[54, 55], as well as reductions in CVD development and 
other type 2 diabetes associated co-morbidities [56, 57]. 
However, changes in vascular health and on other risk 
factors are not totally dependent on improvements in 
CRF. Recently, Pandey et al. observed that patients who 
failed to improve their CRF following a long-term aerobic 
exercise and/or resistance training, did experience signif-
icant improvements in several risk factors (e.g. glycemic 
control and body composition) [58]. Thus, it is possible 
that improvements in vascular health variables may also 
be independent of improvements in CRF.
The present investigation also has some limitations 
that warrant discussion. First, the D2FIT investigation 
had a 1-year follow-up period with only two assessment 
moments for all the vascular health variables (baseline 
and at 1-year). Further assessment points would have 
provided a valuable insight on the progression of struc-
tural and functional vascular indices throughout the 
intervention, especially in the 1st  months. Moreover, 
since this study is part of a secondary analysis it is pos-
sible that number of enrolled patients might be reduced 
to draw significant conclusions on IMT regression after 
1  year. Also, owing to HIIT, it is possible that psycho-
logical fatigue may have set in towards the final months 
of the intervention, raising questions of the long-term 
applicability of this kind of training in patients with type 
2 diabetes.
A major strength of the D2FIT investigation was that, 
unlike previous medium-term investigations [16], D2FIT 
was an intervention with a 1-year duration designed to 
analyze the long-term effects of HIIT on vascular health-
related variables in patients with type 2 diabetes. Another 
strength was that the exercise followed a planned perio-
dization and individualized tailored exercise program 
that was supervised throughout all sessions in an eco-
logical exercise setting. Finally, both exercise groups were 
designed to be iso-energetic based on the assumption 
that the total volume of exercise would meet current PA 
guidelines.
Conclusions
In conclusion, both MCT and HIIT had favorable effects 
on structural arterial variables, such as cIMT, after a 
1-year exercise intervention in patients with type 2 dia-
betes. However, only HIIT had an effective impact on 
peripheral arterial stiffness variables and on local dis-
tensibility of the carotid artery, providing experimental 
evidence to suggest that HIIT can induce clinical mean-
ingful reductions in both structural and functional indi-
ces of vascular health after a 1-year intervention. These 
results may have future implications for exercise inter-
ventions in patients with type 2 diabetes with goals of 
targeting and attenuating the micro- and macrovascular 
changes inherent to this disease.
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